Antitumorigenic Effect of Hsp90 Inhibitor SNX-2112 on Tongue Squamous Cell Carcinoma is Enhanced by Low-Intensity Ultrasound

PURPOSE: The novel Hsp90 inhibitor SNX-2112 showed broad antitumor activity. However, it was still necessary to optimize the therapeutic dosage of SNX-2112 applied on tumors to obtain effective therapy with minimal dose to reduce toxicity. We investigated the role of low-intensity US in promoting an...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:Onco Targets Ther
Main Authors: Nan, Chuanchuan, Zheng, Yuyan, Fan, Haidong, Sun, Haipeng, Huang, Shengxing, Li, Nan
פורמט: Artigo
שפה:Inglês
יצא לאור: Dove 2020
נושאים:
Original Research
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC7434630/
https://ncbi.nlm.nih.gov/pubmed/32884285
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S262174
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים